Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|February 12, 2021
THE INFLUENCE OF HIP ARTHROPLASTY ON HEALTH RELATED QUALITY OF LIFE IN MALE POPULATION WITH OSTEOARTHRITIS HIP DISEASEMonika Białkowska, Tomasz Stołtny, Jarosław Pasek, et al.
Cells|February 25, 2022
Circulating Serum MiRNA-8074 as a Novel Prognostic Biomarker for Multiple MyelomaAneta Szudy-Szczyrek, Radosław Mlak, Michał Mielnik, et al.
Chirurgia Narzadow Ruchu I Ortopedia Polska|October 14, 2008
[The algorithm of physiotherapeutic procedures in patients after total cementless joint arthroplastics]Bogdan Koczy, Tomasz Stołtny, Jan Pajak, et al.
British Journal of Haematology|May 23, 2019
Polymorphisms in the promotor region of the CRBN gene as a predictive factor for peripheral neuropathy in the course of thalidomide-based chemotherapy in multiple myeloma patientsRadosław Mlak, Aneta Szudy-Szczyrek, Marcin Mazurek, et al.
Chirurgia Narzadow Ruchu I Ortopedia Polska|December 17, 2009
[Realloplasty of the acetabular component of the hip joint endoprosthesis without mechanical support systems]Bogdan Koczy, Tomasz Stołtny, Jan Pajak, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|June 13, 2018
Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this diseaseEwelina Grywalska, Małgorzata Bartkowiak-Emeryk, Marcin Pasiarski, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|August 29, 2024
Prognostic factors and clinical characteristics of patients with newly diagnosed non-secretory multiple myeloma in the era of new drugs in "real-world" study: Experiences of the Polish Myeloma GroupGrzegorz Charliński, Aneta Szudy-Szczyrek, Martyna Podgajna, et al.
Annals of Hematology|May 28, 2020
Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimenAneta Szudy-Szczyrek, Radosław Mlak, Michał Mielnik, et al.
British Journal of Haematology|June 23, 2020
Serum brain-derived neurotrophic factor (BDNF) concentration predicts polyneuropathy and overall survival in multiple myeloma patientsAneta Szudy-Szczyrek, Radosław Mlak, Magdalena Bury-Kamińska, et al.
Cancers|February 15, 2022
Expression of CTLA-4 and CD86 Antigens and Epstein-Barr Virus Reactivation in Chronic Lymphocytic Leukemia-Any Link with Known Prognostic Factors?Ewelina Grywalska, Michał Mielnik, Martyna Podgajna, et al.
Pageof 4